• Cindy H Liu, Emily Zhang, Ga Tin Fifi Wong, Sunah Hyun, and Hyeouk Chris Hahm.
• Department of Newborn Medicine, Brigham and Women's Hospital, Boston, MA, USA; School of Social Work, Boston University, Boston, MA, USA; Harvard Medical School. Electronic address: chliu@bwh.harvard.edu.
• Psychiatry Res. 2020 Aug 1; 290: 113172.

AbstractThis study sought to identify factors associated with depression, anxiety, and PTSD symptomatology in U.S. young adults (18-30 years) during the COVID-19 pandemic. This cross-sectional online study assessed 898 participants from April 13, 2020 to May 19, 2020, approximately one month after the U.S. declared a state of emergency due to COVID-19 and prior to the initial lifting of restrictions across 50 U.S. states. Respondents reported high levels of depression (43.3%, PHQ-8 scores ≥ 10), high anxiety scores (45.4%, GAD-7 scores ≥ 10), and high levels of PTSD symptoms (31.8%, PCL-C scores ≥ 45). High levels of loneliness, high levels of COVID-19-specific worry, and low distress tolerance were significantly associated with clinical levels of depression, anxiety, and PTSD symptoms. Resilience was associated with low levels of depression and anxiety symptoms but not PTSD. Most respondents had high levels of social support; social support from family, but not from partner or peers, was associated with low levels of depression and PTSD. Compared to Whites, Asian Americans were less likely to report high levels across mental health symptoms, and Hispanic/Latinos were less likely to report high levels of anxiety. These factors provide initial guidance regarding the clinical management for COVID-19-related mental health problems.Copyright © 2020 Elsevier B.V. All rights reserved.

43 keywords...

hide…